Precigen Inc. Stock
Price
Target price
€3.52
€3.52
1.730%
0.06
1.730%
-
13.05.26 / Stuttgart Stock Exchange
WKN: A2PZG1 / Name: Precigen / Stock / Electrical Utilities & IPPs / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Precigen Inc. Stock
There is an upward development for Precigen Inc. compared to yesterday, with an increase of €0.060 (1.730%).
Pros and Cons of Precigen Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Precigen Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Precigen Inc. | 1.730% | -5.946% | -1.136% | 190.727% | -6.250% | 260.622% | -37.634% |
| Mighty River Power Ltd | 2.960% | 4.192% | 10.127% | 10.127% | 11.538% | -2.793% | -5.946% |
| A2A SpA | 0.470% | -2.430% | -7.616% | 7.377% | 1.393% | 38.425% | 37.607% |
| CEMIG ADR | -2.600% | -3.398% | -12.719% | 26.752% | 16.374% | -10.360% | 45.340% |
News
Precigen Q1 Earnings Call Highlights
Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?
On November 14, San Diego-based Tang Capital Management disclosed a new position in Precigen (NASDAQ:PGEN), adding approximately $40.8 million, or 12.4 million shares, per SEC filings.
According to
